Induction and suppression of immediate-early genes in the rat brain by a selective alpha-2-adrenoceptor agonist and antagonist following noxious peripheral stimulation
暂无分享,去创建一个
A. Pertovaara | A. Pertovaara | R. Bravo | T. Herdegen | R. Bravo | T. Herdegen | Rodrigo Bravo | A. Pertovaara
[1] H. Jalanka. The use of medetomidine, medetomidine-ketamine combinations and atipamezole at Helsinki Zoo--a review of 240 cases. , 1989, Acta veterinaria Scandinavica. Supplementum.
[2] M. Zerial,et al. The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. , 1989, The EMBO journal.
[3] E. Kalso,et al. Involvement of supraspinal and spinal segmental alpha-2-adrenergic mechanisms in the medetomidine-induced antinociception , 1991, Neuroscience.
[4] H. Fields,et al. Putative nociceptive modulatory neurons in the dorsolateral pontomesencephalic reticular formation , 1989, Brain Research.
[5] J. Besson,et al. Peripheral and spinal mechanisms of nociception. , 1987, Physiological reviews.
[6] L. Lau,et al. A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with "zinc finger" sequences. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[7] R. North,et al. Characterization of α2-adrenoceptors which increase potassium conductance in rat locus coeruleus neurones , 1985, Neuroscience.
[8] D. Dubuisson,et al. The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats , 1977, Pain.
[9] J. Savola,et al. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. , 1988, European journal of pharmacology.
[10] K. Berkley,et al. Diencephalic mechanisms of pain sensation , 1985, Brain Research Reviews.
[11] R. Tsien,et al. α-Adrenergic inhibition of sympathetic neurotransmitter release mediated by modulation of N-type calcium-channel gating , 1989, Nature.
[12] M. Scheinin,et al. Behavioural and neurochemical effects of medetomidine, a novel veterinary sedative. , 1988, European journal of pharmacology.
[13] D. Carter,et al. Neurotransmitter-stimulated immediate-early gene responses are organized through differential post-synaptic receptor mechanisms. , 1992, Brain research. Molecular brain research.
[14] M. Scheinin,et al. Behavioural and neurochemical effects of antipamezole, a novel α2-adrenoceptor antagonist , 1988 .
[15] B. Bean. Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence , 1989, Nature.
[16] J. Savola,et al. Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole. , 1989, Archives internationales de pharmacodynamie et de therapie.
[17] M. Scheinin,et al. Behavioural and neurochemical effects of atipamezole, a novel α2-adreneceptor antagonist , 1988 .
[18] S. Hunt,et al. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation , 1987, Nature.
[19] R. Dubner,et al. Preproenkephalin mrna in spinal dorsal horn neurons is induced by peripheral inflammation and is co-localized with Fos and Fos-related proteins , 1992, Neuroscience.
[20] M. Kuhar,et al. Distribution of α2 agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents , 1984, Brain Research Reviews.
[21] P. Lemaire,et al. Two mouse genes encoding potential transcription factors with identical DNA-binding domains are activated by growth factors in cultured cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[22] H. Tanila,et al. Effect of systemic medetomidine, an alpha 2 adrenoceptor agonist, on experimental pain in humans. , 1991, Anesthesiology.
[23] R. Bravo,et al. Specific temporal and spatial distribution of JUN, FOS, and KROX‐24 proteins in spinal neurons following noxious transsynaptic stimulation , 1991, The Journal of comparative neurology.
[24] J. Besson,et al. The spino(trigemino)pontoamygdaloid pathway: electrophysiological evidence for an involvement in pain processes. , 1990 .
[25] W. Zieglgänsberger,et al. Sequential expression of JUN B, JUN D and FOS B proteins in rat spinal neurons: Cascade of transcriptional operations during nociception , 1991, Neuroscience Letters.
[26] K. Lynch,et al. Distribution of α2-adrenergic receptor mRNAs in the rat CNS , 1991 .
[27] M. Scheinin,et al. Dexmedetomidine, an alpha 2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery. , 1990, Anesthesiology.
[28] P. Gass,et al. Induction of immediate early gene encoded proteins in the rat hippocampus after bicuculline-induced seizures: Differential expression of KROX-24, FOS and JUN proteins , 1992, Neuroscience.
[29] Dept . Anatomy,et al. Morphine or U‐50,488 suppresses fos protein‐like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat , 1992, The Journal of comparative neurology.
[30] R. Bravo,et al. Expression of different Jun and Fos proteins during the G0-to-G1 transition in mouse fibroblasts: in vitro and in vivo associations , 1991, Molecular and cellular biology.
[31] E. Bullitt. Expression of C‐fos‐like protein as a marker for neuronal activity following noxious stimulation in the rat , 1990, The Journal of comparative neurology.
[32] J. Hieble,et al. Structure and function of alpha-adrenoceptors. , 1991, Pharmacological reviews.
[33] B. Mellström,et al. Molecular pathways of pain: Fos/Jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene , 1991, Neuron.
[34] J. Savola,et al. Central alpha 2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidine. , 1991, European journal of pharmacology.
[35] M. Zimmermann,et al. The KROX-24 protein, a new transcription regulating factor: Expression in the rat central nervous system following afferent somatosensory stimulation , 1990, Neuroscience Letters.
[36] E. Kalso,et al. FLFQPQRF-amide modulatesα2-adrenergic antinociception in the rat dorsal horn in vivo , 1991, Brain Research.
[37] J. Fairhurst,et al. Adrenergic receptors mediate changes in c-fos mRNA levels in brain. , 1989, Brain research. Molecular brain research.
[38] A. Pertovaara,et al. The effect of medetomidine, an α2-adrenoceptor agonist, in various pain tests , 1990 .
[39] H. Ruskoaho,et al. EVIDENCE FOR MEDETOMIDINE AS A SELECTIVE AND POTENT AGONIST α2‐ADRENORECEPTORS , 1986 .
[40] W. Zieglgänsberger,et al. Opiates modify induction of c-fos proto-oncogene in the spinal cord of the rat following noxious stimulation , 1990, Neuroscience Letters.
[41] T. Curran,et al. Regulation of proenkephalin by Fos and Jun. , 1989, Science.
[42] G. Bing,et al. Noradrenergic activation of immediate early genes in rat cerebral cortex. , 1991, Brain research. Molecular brain research.
[43] L. Lau,et al. A gene activated by growth factors is related to the oncogene v-jun. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[44] James I. Morgan,et al. Role of ion flux in the control of c-fos expression , 1986, Nature.
[45] M. Iadarola,et al. In situ hybridization histochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[46] R. Nahin,et al. Spinal lamina I projection neurons in the rat: Collateral innervation of parabrachial area and thalamus , 1989, Neuroscience.
[47] J. Wikberg,et al. Rat Spinal Cord α2‐Adrenoceptors are of the α2A‐Subtype: Comparison with α2A‐ and α2B‐Adrenoceptors in Rat Spleen, Cerebral Cortex and Kidney Using 3H‐RX821002 Ligand Binding , 1991 .
[48] A. Basbaum,et al. The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: Correlation of nociceptive behavior and c-fos expression , 1991, Neuroscience.
[49] A I Basbaum,et al. Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[50] J. Milbrandt,et al. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. , 1987, Science.
[51] M. Scheinin,et al. Comparison of the behavioral and neurochemical effects of the two optical enantiomers of medetomidine, a selective alpha-2-adrenoceptor agonist. , 1991, The Journal of pharmacology and experimental therapeutics.
[52] T. Yaksh,et al. Antinociceptive properties of intrathecal dexmedetomidine in rats. , 1991, European journal of pharmacology.
[53] M. Dragunow,et al. Kindling stimulation induces c-fos protein(s) in granule cells of the rat dentate gyrus , 1987, Nature.
[54] H. Scheinin,et al. The analgesic action of dexmedetomidine — a novel α 2-adrenoceptor agonist — in healthy volunteers , 1991, Pain.
[55] E. Kalso,et al. Spinal Antinociception by Dexmedetomidine, a Highly Selective α2-Adrenergic Agonist , 1991 .
[56] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[57] A. Pertovaara. Antinociception in bulboreticular neurons of the rat produced by spinally administered medetomidine, an alpha 2-adrenoceptor agonist. , 1991, European journal of pharmacology.